Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Dec;90(12):1245-1253.
doi: 10.1007/s12098-023-04613-w. Epub 2023 Jun 16.

Respiratory Syncytial Virus Infection: An Update

Akshita Soni  1 , S K Kabra  1 , Rakesh Lodha  2
Affiliations
Review

Respiratory Syncytial Virus Infection: An Update

Akshita Soni et al. Indian J Pediatr. 2023 Dec.

Abstract

Respiratory syncytial virus (RSV) is a highly contagious respiratory virus that can cause mild to severe illness in children. It is the leading cause of lower respiratory tract infections (LRTI) in children under the age of one year, and it can also affect older children and adults, especially those with underlying medical conditions. In the post-COVID period, there seems to be an increase in the incidence, possibly due to 'immunity debt'. Symptoms of RSV infection in children may include fever, runny nose, and cough. In severe cases, it can lead to bronchiolitis (inflammation of the small airways in the lungs) or pneumonia (infection of the lungs). Most children with RSV infection recover within a week or two, but some may require hospitalization, especially those who are premature or have underlying medical conditions. As there is no specific treatment for RSV infection, supportive care is the mainstay of management. In severe cases, oxygen therapy or mechanical ventilation may be necessary. High flow nasal cannula seems to be beneficial. There have been promising advances in development of RSV vaccines; few trials in adults and pregnant women have reported encouraging results. The US FDA has approved two RSV vaccines for use in older adults (GSK's Arexvy and Pfizer's ABRYSVO).

Keywords: Bronchiolitis; Palivizumab; Respiratory syncytial virus; Vaccine.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Mammas IN, Drysdale SB, Rath B, et al. Update on current views and advances on RSV infection (review). Int J Mol Med. 2020;46:509–20. - DOI - PubMed - PMC
    1. Gagliardi TB, Criado MF, Proença-Módena JL, et al. Syncytia induction by clinical isolates of human respiratory syncytial virus A. Intervirology. 2017;60:56–60. - DOI - PubMed
    1. Taleb SA, Al Thani AA, Al Ansari K, Yassine HM. Human respiratory syncytial virus: Pathogenesis, immune responses, and current vaccine approaches. Eur J Clin Microbiol Infect Dis. 2018;37:1817–27. - DOI - PubMed
    1. Ghia C, Rambhad G. Disease burden due to respiratory syncytial virus in Indian pediatric population: a literature review. Clin Med Insights Pediatr. 2021;15:11795565211029250. - DOI - PubMed - PMC
    1. Abbasi J. This is our COVID”—What physicians need to know about the pediatric RSV surge. JAMA. 2022;328:2096–8. - DOI

Substances

LinkOut - more resources